Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complementary and alternative medicine in multiple sclerosis.

Continuum (Minneapolis, Minn.)·2012
Same journal

Sports Neurology.

Neurologic clinics·2026
Same journal

Sports-Related Peripheral Nerve Injuries.

Neurologic clinics·2026
Same journal

Active Rehabilitation and Return to Play in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Autonomic Assessment and Management in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Management of Vestibular Symptoms in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Neuropsychological Assessment in Sport-Related Concussion: Evidence, Controversies, and Clinical Applications.

Neurologic clinics·2026
See all related articles

Related Experiment Video

Updated: Jun 3, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Complementary and alternative medicine and multiple sclerosis.

Allen C Bowling1

  • 1MS Service, Colorado Neurological Institute, 701 East Hampden Avenue, #320, Englewood, CO 80113, USA. abneurocare@qwestoffice.net

Neurologic Clinics
|March 29, 2011
PubMed
Summary
This summary is machine-generated.

Many multiple sclerosis (MS) patients use complementary and alternative medicine (CAM). Discussing CAM's varying risks and benefits with healthcare providers can improve patient care and outcomes.

More Related Videos

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

Related Experiment Videos

Last Updated: Jun 3, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

Area of Science:

  • Integrative medicine
  • Neurology
  • Patient-centered care

Background:

  • Complementary and alternative medicine (CAM) is widely adopted by individuals with multiple sclerosis (MS), with usage rates ranging from 50% to 75%.
  • The integration of CAM into conventional medical care for MS patients is often limited, with discussions about these therapies infrequently occurring during routine appointments.
  • CAM therapies present a diverse spectrum of potential benefits and risks for MS management, encompassing options that are low-risk and potentially helpful, alongside those that are unproven, ineffective, or even hazardous.

Purpose of the Study:

  • To highlight the widespread use of complementary and alternative medicine (CAM) among multiple sclerosis (MS) patients.
  • To underscore the importance of discussing the varied risk-benefit profiles of CAM therapies with healthcare professionals.
  • To emphasize how providing objective information on CAM can enhance the quality of care for individuals with MS.

Main Methods:

  • Literature review and synthesis of existing data on CAM usage in multiple sclerosis.
  • Analysis of the risk-benefit profiles associated with various CAM modalities.
  • Discussion of the role of healthcare providers in informing patients about CAM.

Main Results:

  • A significant proportion of multiple sclerosis patients utilize CAM therapies.
  • CAM therapies demonstrate a wide range of efficacy and safety, from beneficial to dangerous or unstudied.
  • CAM is often not discussed within the context of conventional medical consultations for MS.

Conclusions:

  • Healthcare professionals should proactively engage in discussions regarding CAM with MS patients.
  • Objective and practical information on CAM risks and benefits is crucial for informed decision-making.
  • Improved communication about CAM can lead to better quality of care and potentially improved outcomes for individuals with MS.